PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-8.89%
Negative revenue growth while ADI stands at 7.48%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-8.13%
Negative gross profit growth while ADI is at 31.23%. Joel Greenblatt would examine cost competitiveness or demand decline.
-13.11%
Negative EBIT growth while ADI is at 130.06%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-12.58%
Negative operating income growth while ADI is at 130.06%. Joel Greenblatt would press for urgent turnaround measures.
-73.23%
Negative net income growth while ADI stands at 404.45%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-72.87%
Negative EPS growth while ADI is at 538.89%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-73.02%
Negative diluted EPS growth while ADI is at 533.33%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.30%
Share reduction while ADI is at 0.48%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.10%
Reduced diluted shares while ADI is at 0.82%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
23.81%
Maintaining or increasing dividends while ADI cut them. John Neff might see a strong edge in shareholder returns.
12.02%
OCF growth under 50% of ADI's 275.94%. Michael Burry might suspect questionable revenue recognition or rising costs.
10.55%
FCF growth under 50% of ADI's 234.54%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
46.89%
10Y revenue/share CAGR under 50% of ADI's 147.31%. Michael Burry would suspect a lasting competitive disadvantage.
42.24%
5Y revenue/share CAGR at 50-75% of ADI's 82.34%. Martin Whitman would worry about a lagging mid-term growth trajectory.
21.89%
3Y revenue/share CAGR under 50% of ADI's 59.63%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
88.82%
10Y OCF/share CAGR under 50% of ADI's 184.09%. Michael Burry would worry about a persistent underperformance in cash creation.
100.89%
5Y OCF/share CAGR at 75-90% of ADI's 123.26%. Bill Ackman would push for operational improvements to match competitor’s mid-term gains.
61.14%
3Y OCF/share CAGR at 50-75% of ADI's 106.10%. Martin Whitman would suspect weaker recent execution or product competitiveness.
-36.54%
Negative 10Y net income/share CAGR while ADI is at 187.84%. Joel Greenblatt sees a major red flag in long-term profit erosion.
47.24%
5Y net income/share CAGR at 75-90% of ADI's 59.53%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
-55.69%
Negative 3Y CAGR while ADI is 169.74%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
44.34%
Below 50% of ADI's 252.23%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
6.56%
Below 50% of ADI's 100.59%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
5.71%
Below 50% of ADI's 80.12%. Michael Burry suspects a serious short-term disadvantage in building book value.
516.71%
10Y dividend/share CAGR above 1.5x ADI's 143.94%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
193.79%
5Y dividend/share CAGR above 1.5x ADI's 50.15%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
82.37%
3Y dividend/share CAGR above 1.5x ADI's 20.99%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-18.91%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
2.57%
Inventory shrinking or stable vs. ADI's 5.99%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
4.21%
Asset growth above 1.5x ADI's 0.12%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-5.64%
We have a declining book value while ADI shows 1.91%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
13.79%
We have some new debt while ADI reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
2.93%
We increase R&D while ADI cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-0.73%
We cut SG&A while ADI invests at 0.95%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.